CancerVax Corporation (NASDAQ: CNVX), a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment of cancer, announced today that David F. Hale, President and Chief Executive Officer, will present at the BIO CEO & Investor Conference 2006 on Tuesday, February 14, 2006 at 11:30 a.m. Eastern Standard Time (EST) at the Waldorf Astoria Hotel in New York City. Mr. Hale will provide an overview of CancerVax's proposed merger with Micromet AG, and an update on the development status of the Company's product candidates.
